Bloks Group Limited — AGM Information 2006

Mar 6, 2006

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

HONG KONG PHARMACEUTICAL HOLDINGS LIMITED 香港葯業集團有限公司[*]

(Provisional Liquidators Appointed)

(Incorporated in Bermuda with limited liability)

(Stock Code: 0182)

NOTICE OF ANNUAL GENERAL MEETING AND FORM OF PROXY

NOTICE IS HEREBY GIVEN that an ANNUAL GENERAL MEETING of Hong Kong Pharmaceutical Holdings Limited (Provisional Liquidators Appointed) (the “Company”) will be held at Room 103, The Duke of Windsor Social Service Building, 15 Hennessy Road, Wan Chai, Hong Kong, on Tuesday, 28 March 2006, at 10:00 a.m. to pass an ordinary resolution to receive and adopt the audited consolidated financial statements and the reports of the Provisional Liquidators and the auditors for the years ended 31 March 2004 and 2005.

Notes:

1. Any member of the Company entitled to attend and vote at the annual general meeting (or at any adjournment thereof) is entitled to appoint one or more person(s) as his proxy to attend and vote instead of him. A proxy need not be a member of the Company.

2. To be valid, proxy form, attached to this announcement, together with any power of attorney or other authority (if any) under which it is signed or notarially certified copy thereof, must be lodged with the Company’s branch share registrar, Tengis Limited at 26th Floor, Tesbury Centre, 28 Queen’s Road East, Wan Chai, Hong Kong not less than 48 hours before the time appointed for holding the annual general meeting (or any adjournment thereof).

3. Completion and return of the form of proxy will not preclude members from attending and voting at the annual general meeting (or any adjournment thereof).

Trading in the shares of the Company has been suspended with effect from 5 August 2004 and will remain suspended until further notice.

As at the date of this announcement, the board of directors of the Company comprises five executive directors, namely, Mr Sun Hiu Lu, Ms Huang Shuyun, Mr Chu Kwan, Mr Zhao Dake and Mr Zhang Ke, Winston, and three independent non-executive directors, namely Mr Ng Wing Hang, Dr Melvin Wong and Mr Chu Yu Lin, David.

1

For and on behalf of HONG KONG PHARMACEUTICAL HOLDINGS LIMITED (Provisional Liquidators Appointed) Kelvin Flynn Cosimo Borrelli

Joint and Several Provisional Liquidators acting as agent for and on behalf of the Company without personal liability

• 3 March 2006, Hong Kong

• for identification purposes only

Please also refer to the published version of this announcement in China Daily.

2